Insmed | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Cytokinetics USD 57.37M 4.97M 2025-03
DBV Technologies USD 6.24M 1.32M 2024-09
Dynavax Technologies USD 106.33M 64.74M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Insmed USD 142.51M 23.58M 2024-12
Novartis USD 3.5B 368M 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Insmed Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.